Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Blanchard

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
The FEBS Journal|June 17, 2015
Structural characterization of human galectin-4 C-terminal domain: elucidating the molecular basis for recognition of glycosphingolipids, sulfated saccharides and blood group antigensKhuchtumur Bum-Erdene, Hakon Leffler, Ulf J Nilsson, et al.
Journal of Molecular Biology|February 20, 2007
Insight into host cell carbohydrate-recognition by human and porcine rotavirus from crystal structures of the virion spike associated carbohydrate-binding domain (VP8*)Helen Blanchard, Xing Yu, Barbara S Coulson, et al.
Expert Opinion on Therapeutic Patents|August 12, 2014
Galectin-3 inhibitors: a patent review (2008-present)Helen Blanchard, Xing Yu, Patrick Michael Collins, et al.
Scientific Reports|February 2, 2016
Structural characterisation of human galectin-4 N-terminal carbohydrate recognition domain in complex with glycerol, lactose, 3'-sulfo-lactose, and 2'-fucosyllactoseKhuchtumur Bum-Erdene, Hakon Leffler, Ulf J Nilsson, et al.
Proteins|November 21, 2025
Molecular Dynamics Identify Variances Between Galectin Carbohydrate-Binding Sites That Impact the Binding Site Conformation and Ligand BindingRob Marc Go, Chandan Kishor, Alpeshkumar K Malde, et al.
Chemical Biology & Drug Design|March 29, 2020
Linear triazole-linked pseudo oligogalactosides as scaffolds for galectin inhibitor developmentChristophe Dussouy, Chandan Kishor, Annie Lambert, et al.
Chemical Biology & Drug Design|December 6, 2011
Taloside inhibitors of galectin-1 and galectin-3Patrick M Collins, Christopher T Oberg, Hakon Leffler, et al.
RSC Chemical Biology|July 30, 2025
Synergy of triazolyl substituents at C1 and C3 of galactose for high-affinity and selective galectin-4C inhibitionAlexander Dahlqvist, Rob Marc Go, Chandan Kishor, et al.
Carbohydrate Research|March 7, 2012
Synthesis of lactosylated glycoclusters and inhibition studies with plant and human lectinsSamy Cecioni, Susan E Matthews, Helen Blanchard, et al.
Chembiochem : a European Journal of Chemical Biology|August 8, 2015
Substantial Receptor-induced Structural Rearrangement of Rotavirus VP8*: Potential Implications for Cross-Species InfectionXing Yu, Rahul Mishra, Gavan Holloway, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
The FEBS Journal|June 17, 2015
Structural characterization of human galectin-4 C-terminal domain: elucidating the molecular basis for recognition of glycosphingolipids, sulfated saccharides and blood group antigensKhuchtumur Bum-Erdene, Hakon Leffler, Ulf J Nilsson, et al.
Journal of Molecular Biology|February 20, 2007
Insight into host cell carbohydrate-recognition by human and porcine rotavirus from crystal structures of the virion spike associated carbohydrate-binding domain (VP8*)Helen Blanchard, Xing Yu, Barbara S Coulson, et al.
Expert Opinion on Therapeutic Patents|August 12, 2014
Galectin-3 inhibitors: a patent review (2008-present)Helen Blanchard, Xing Yu, Patrick Michael Collins, et al.
Scientific Reports|February 2, 2016
Structural characterisation of human galectin-4 N-terminal carbohydrate recognition domain in complex with glycerol, lactose, 3'-sulfo-lactose, and 2'-fucosyllactoseKhuchtumur Bum-Erdene, Hakon Leffler, Ulf J Nilsson, et al.
Proteins|November 21, 2025
Molecular Dynamics Identify Variances Between Galectin Carbohydrate-Binding Sites That Impact the Binding Site Conformation and Ligand BindingRob Marc Go, Chandan Kishor, Alpeshkumar K Malde, et al.
Chemical Biology & Drug Design|March 29, 2020
Linear triazole-linked pseudo oligogalactosides as scaffolds for galectin inhibitor developmentChristophe Dussouy, Chandan Kishor, Annie Lambert, et al.
Chemical Biology & Drug Design|December 6, 2011
Taloside inhibitors of galectin-1 and galectin-3Patrick M Collins, Christopher T Oberg, Hakon Leffler, et al.
RSC Chemical Biology|July 30, 2025
Synergy of triazolyl substituents at C1 and C3 of galactose for high-affinity and selective galectin-4C inhibitionAlexander Dahlqvist, Rob Marc Go, Chandan Kishor, et al.
Carbohydrate Research|March 7, 2012
Synthesis of lactosylated glycoclusters and inhibition studies with plant and human lectinsSamy Cecioni, Susan E Matthews, Helen Blanchard, et al.
Chembiochem : a European Journal of Chemical Biology|August 8, 2015
Substantial Receptor-induced Structural Rearrangement of Rotavirus VP8*: Potential Implications for Cross-Species InfectionXing Yu, Rahul Mishra, Gavan Holloway, et al.
Pageof 6